Given these premises, the RESTORE-2 study aimed at assessing the comparative effectiveness and safety of Gla-300 versus Deg-100 in a cohort of insulin-naïve patients with T2D followed under routine care in Italian diabetes outpatient clinics. Here, INS is linked to type 2 diabetes mellitus.